Brief: Paion Says Acacia Pharma Launches Byfavo(Tm) In U.S.
Jan 28 (Reuters) - ACACIA PHARMA GROUP PLC ACPH.BR :
* ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE
U.S. FOR
PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES
LASTING 30 MINUTES OR LESS
* APPROXIMATELY 40 MILLION PROCEDURES TAKE PLACE ANNUALLY IN
U.S.
THAT REQUIRE USE OF PROCEDURAL SEDATION
Source text for Eikon: ID:nEQ2X06Vpa
Further company coverage: ACPH.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on PAION AG
See all newsBrief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
Brief: Paion AG Reports Developments On Commercial Activities In Europe
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022